Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes
EXPLORE
P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes
1 other identifier
observational
5,580
0 countries
N/A
Brief Summary
Examine red and white blood cells of PNH patients with bone marrow failure syndromes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2010
CompletedFirst Posted
Study publicly available on registry
September 1, 2010
CompletedSeptember 1, 2010
August 1, 2010
August 30, 2010
August 31, 2010
Conditions
Keywords
Eligibility Criteria
Patients at least 10 years of age with aplastic anemia, myelodyplastic syndromes or other bone marrow failure syndromes.
You may qualify if:
- At least 10 years of age.
- Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes
You may not qualify if:
- Has any condition that might interfere with the patient's participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 30, 2010
First Posted
September 1, 2010
Last Updated
September 1, 2010
Record last verified: 2010-08